Moody Aldrich Partners LLC Axsome Therapeutics, Inc. Transaction History
Moody Aldrich Partners LLC
- $425 Million
- Q1 2025
A detailed history of Moody Aldrich Partners LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Moody Aldrich Partners LLC holds 62,339 shares of AXSM stock, worth $6.85 Million. This represents 1.71% of its overall portfolio holdings.
Number of Shares
62,339
Previous 45,138
38.11%
Holding current value
$6.85 Million
Previous $3.82 Million
90.36%
% of portfolio
1.71%
Previous 0.8%
Shares
24 transactions
Others Institutions Holding AXSM
# of Institutions
358Shares Held
36.4MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$445 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$429 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$363 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$161 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$153 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.71B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...